Johansson et al. show that plasma GFAP begins to increase 10 years before symptom onset in Alzheimer’s disease, prior to P-tau181 and NfL, suggesting that GFAP is mirroring pathology upstream of tau phosphorylation and neurodegeneration. bit.ly/3XB0QVBpic.twitter.com/rHWZmILEeI
Teacher, Clinical Supervisor
Clinical Associate Professor, Psychiatry
University of Florida
Affiliation is for identification only. All content and opinions are my own.
View more posts
Gator Psychiatry 